April 28, 2017
In His Own Words: Dr. Jerry Greenberg
In 2017, over 180,000 men in the U.S. will be diagnosed with prostate cancer. Over 26,000 of those men will die from prostate cancer. Because of prostate cancer’s widespread impact, Vituro Health seeks to empower men, their families and the doctors who treat them with resources and services that elevate the standard of care and improve the overall patient experience. The passion for this vision is clear when you speak to our individual doctors and leadership. We previously shared why Vituro Health partner physician Tracy Gapin believes physician communication is essential.
Now, Vituro Health partner physician Dr. Jerry Greenberg explains the importance of PSA testing when it comes to prostate health.
“PSA is a lot of things: as an acronym it stands for Prostate Specific Antigen, as a blood test it is most often used to screen or identify patients at risk for having prostate cancer, as an enzyme in the prostate it assists with reproduction, and as a tumor marker it also guides prostate cancer treatment. But recently PSA has been accused of causing more harm then good. How can that be? It is true that PSA as a screening test does produce false positives. In other words you as a patient may have a high PSA and not have prostate cancer. Therefore PSA must be interpreted carefully by a trained professional (usually a urologist). You see by itself, PSA is only a number. By itself PSA means nothing. And in the wrong context it can cause undue anxiety and yes possibly harm, especially if it leads to unnecessary biopsies. Fortunately, PSA when used correctly (along with other tests like the blood tests: the 4k, or the prostate health index), can save lives. And when used along with the latest imaging modalities like a multi-parametric MRI, PSA starts to fulfill the primary goal of any cancer screening— find and treat potentially lethal cancers before they do harm.” To learn more about Vituro Health’s comprehensive prostate care, call: 866-4VITURO (848876).